Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Jade Biosciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 70
- +14 vs. Q3 2022
- Shares held
- 27.4M
- +421.8K (+1.6%) vs. Q3 2022
- Total value
- $802.9M
- +$355.6M (+79.5%) vs. Q3 2022
- New holders
- 24
- 17 more added
- Sold out
- 10
- 22 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 8,263,982 | $242.1M | 4.91% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,758,686 | $110.1M | 6.69% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 2,017,521 | $59.1M | 7.12% | −310,388−13.3% | Reduced |
| Baker Bros. Advisors LP | 1,976,868 | $57.9M | 0.35% | −2,700−0.1% | Reduced |
| Cormorant Asset Management, LP | 1,957,132 | $57.3M | 3.85% | −373,559−16.0% | Reduced |
| Citadel Advisors LLC | 1,561,923 | $45.8M | 0.05% | −53,655−3.3% | Reduced |
| TCG Crossover Management, LLC | 1,081,274 | $31.7M | 5.59% | +121,702+12.7% | Added |
| OrbiMed Advisors LLC | 759,540 | $22.3M | 0.43% | −35,460−4.5% | Reduced |
| VR Adviser, LLC | 747,869 | $21.9M | 3.69% | −86,058−10.3% | Reduced |
| Octagon Capital Advisors LP | 621,712 | $18.2M | 2.84% | +621,712 | New |
| BlackRock Inc. | 607,983 | $17.8M | 0.00% | −107,462−15.0% | Reduced |
| OUP Management Co., LLC | 603,762 | $17.7M | 28.88% | 00.0% | Unchanged |
| Vanguard Group Inc | 499,477 | $14.6M | 0.00% | +33,245+7.1% | Added |
| FMR LLC | 457,187 | $13.4M | 0.00% | −67,873−12.9% | Reduced |
| Great Point Partners LLC | 378,522 | $11.1M | 2.29% | +378,522 | New |
| Soleus Capital Management, L.P. | 217,119 | $6.36M | 0.91% | +217,119 | New |
| State Street Corp | 192,184 | $5.63M | 0.00% | +19,006+11.0% | Added |
| Geode Capital Management, LLC | 178,596 | $5.23M | 0.00% | +8,997+5.3% | Added |
| Point72 Asset Management, L.P. | 175,022 | $5.13M | 0.02% | +175,022 | New |
| Fred Alger Management, LLC | 147,955 | $4.34M | 0.02% | −34,326−18.8% | Reduced |
| Ghost Tree Capital, LLC | 135,000 | $3.96M | 1.69% | −15,000−10.0% | Reduced |
| Ikarian Capital, LLC | 127,921 | $3.75M | 1.56% | −72,079−36.0% | Reduced |
| Millennium Management LLC | 123,208 | $3.61M | 0.00% | +39,578+47.3% | Added |
| Eversept Partners, LP | 91,252 | $2.67M | 0.25% | +91,252 | New |
| Northern Trust Corp | 78,199 | $2.29M | 0.00% | +3,371+4.5% | Added |
| Invesco Ltd. | 72,579 | $2.13M | 0.00% | +72,579 | New |
| Skandinaviska Enskilda Banken AB (publ) | 53,340 | $1.56M | 0.01% | −3,091−5.5% | Reduced |
| Nan Fung Group Holdings Ltd | 50,616 | $1.48M | 1.02% | +50,616 | New |
| Nuveen Asset Management, LLC | 37,112 | $1.09M | 0.00% | +2,136+6.1% | Added |
| Silverarc Capital Management, LLC | 36,906 | $1.08M | 0.37% | +36,906 | New |
| D. E. Shaw & Co., Inc. | 29,494 | $864.2K | 0.00% | −4,801−14.0% | Reduced |
| Bank of New York Mellon Corp | 28,094 | $823.2K | 0.00% | +548+2.0% | Added |
| Boothbay Fund Management, LLC | 25,813 | $756.3K | 0.03% | −9,944−27.8% | Reduced |
| Charles Schwab Investment Management Inc | 24,641 | $722.0K | 0.00% | +885+3.7% | Added |
| Ensign Peak Advisors, Inc | 21,208 | $621.4K | 0.00% | +21,208 | New |
| Two Sigma Investments, LP | 21,137 | $619.3K | 0.00% | +21,137 | New |
| Swiss National Bank | 20,701 | $606.5K | 0.00% | +20,701 | New |
| Parkwood LLC | 20,560 | $602.0K | 0.12% | −784−3.7% | Reduced |
| Cheyne Capital Management (UK) LLP | 18,927 | $554.6K | 0.98% | +18,927 | New |
| Renaissance Technologies LLC | 18,100 | $530.0K | 0.00% | +18,100 | New |
| Alps Advisors Inc | 16,685 | $488.9K | 0.00% | +16,685 | New |
| Nantahala Capital Management, LLC | 15,700 | $460.0K | 0.04% | +15,700 | New |
| Rhumbline Advisers | 14,232 | $417.0K | 0.00% | +90+0.6% | Added |
| Price T Rowe Associates Inc | 13,225 | $387.0K | 0.00% | +13,225 | New |
| Trustees of Columbia University in the City of New York | 13,190 | $386.0K | 0.80% | +13,190 | New |
| California State Teachers Retirement System | 11,081 | $324.7K | 0.00% | +7,456+205.7% | Added |
| Credit Suisse AG | 9,071 | $265.8K | 0.00% | +9,021+18,042.0% | Added |
| State of Wisconsin Investment Board | 8,567 | $251.0K | 0.00% | +8,567 | New |
| Old Well Partners, LLC | 8,092 | $237.1K | 0.21% | +8,092 | New |
| New York State Common Retirement Fund | 7,673 | $224.8K | 0.00% | −13−0.2% | Reduced |
| Bank of America Corp | 7,556 | $221.4K | 0.00% | −5,171−40.6% | Reduced |
| JPMorgan Chase & Co | 5,267 | $154.0K | 0.00% | −1,557−22.8% | Reduced |
| MetLife Investment Management | 5,228 | $153.2K | 0.00% | +5,228 | New |
| American International Group, Inc. | 4,344 | $127.3K | 0.00% | −16−0.4% | Reduced |
| Barclays PLC | 3,870 | $113.4K | 0.00% | +3,481+894.9% | Added |
| Deutsche Bank AG | 3,782 | $110.8K | 0.00% | +60+1.6% | Added |
| Legal & General Group Plc | 3,235 | $94.8K | 0.00% | +2,461+318.0% | Added |
| Cubist Systematic Strategies, LLC | 3,206 | $93.9K | 0.00% | +3,206 | New |
| STRS Ohio | 2,300 | $67.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,190 | $64.2K | 0.00% | −2,574−54.0% | Reduced |
| Royal Bank of Canada | 1,498 | $44.0K | 0.00% | +1,051+235.1% | Added |
| Amalgamated Bank | 1,199 | $35.0K | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 1,175 | $34.4K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,144 | $34.0K | 0.00% | −2,305−66.8% | Reduced |
| Metropolitan Life Insurance Co | 701 | $20.5K | 0.00% | +701 | New |
| Ameritas Investment Partners, Inc. | 772 | $17.8K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 349 | $10.2K | 0.00% | −159−31.3% | Reduced |
| Federated Hermes, Inc. | 84 | $2.46K | 0.00% | +84 | New |
| Ellevest, Inc. | 3 | $88 | 0.00% | +2+200.0% | Added |
| Nisa Investment Advisors, LLC | 4 | $0 | 0.00% | +4 | New |
| Lynx1 Capital Management LP | 0 | $0 | 0.00% | −276,447−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −51,000−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −46,864−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −10,574−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −3,962−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,612−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −229−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −28−100.0% | Sold out |